Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sildenafil/testosterone - Emotional Brain

Drug Profile

Sildenafil/testosterone - Emotional Brain

Alternative Names: Lybrido; Testosterone/sildenafil

Latest Information Update: 12 Jan 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Emotional Brain
  • Developer Companion Diagnostics BV; Emotional Brain
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Phenyl ethers; Piperazines; Purines; Small molecules; Sulfones; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Female sexual dysfunction

Most Recent Events

  • 09 Jan 2018 Efficacy and safety data from a phase II trial in Female sexual dysfunction released by Emotional Brain
  • 05 Jan 2016 A phase III trial for Female sexual dysfunction is still being planned in USA and Europe
  • 20 Apr 2015 Sildenafil/testosterone has patent protection in USA, Europe, China, Australia, Mexico and Hong Kong
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top